No abstract available
MeSH terms
-
Adolescent
-
Age Factors
-
Antiviral Agents / administration & dosage*
-
Antiviral Agents / pharmacology
-
COVID-19
-
Child
-
Child, Preschool
-
China
-
Chloroquine / administration & dosage
-
Chloroquine / analogs & derivatives
-
Coronavirus Infections / diagnosis
-
Coronavirus Infections / drug therapy*
-
Coronavirus Infections / epidemiology
-
Female
-
Humans
-
Indoles / administration & dosage
-
Infant
-
Infant, Newborn
-
Interferon-alpha / administration & dosage
-
Lopinavir / administration & dosage
-
Male
-
Pandemics
-
Pharmaceutical Services*
-
Pneumonia, Viral / diagnosis
-
Pneumonia, Viral / drug therapy*
-
Pneumonia, Viral / epidemiology
-
Practice Guidelines as Topic*
-
Prognosis
-
Ribavirin / administration & dosage
-
Risk Assessment
-
Severe Acute Respiratory Syndrome / diagnosis
-
Severe Acute Respiratory Syndrome / drug therapy*
-
Severe Acute Respiratory Syndrome / epidemiology
-
Treatment Outcome
Substances
-
Antiviral Agents
-
Indoles
-
Interferon-alpha
-
Lopinavir
-
Ribavirin
-
chloroquine diphosphate
-
Chloroquine
-
umifenovir